Joyce F. Liu
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 95
- Oncology top 0.5%
- PARP inhibition in cancer therapy 53
- Cancer Immunotherapy and Biomarkers 11
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 16
- Immunology top 2%
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 20
-
- BRCA gene mutations in cancer 18
-
- Cancer Mechanisms and Therapy 15
-
- DNA Repair Mechanisms 13
- Co-authors
- Ursula A. MatulonisPanagiotis A. KonstantinopoulosRonny DrapkinElise C. KohnMichelle S. HirschAlan D. D’AndreaBrooke E. HowittDipanjan Chowdhury
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Nucleic Acids Research (2 papers)Nature Communications (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Joyce F. Liu
172 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Reproductive Medicine 2.1k
- Oncology 3.9k
- Cancer Research 903
- Immunology 1.1k
- Obstetrics and Gynecology 417
Countries citing papers authored by Joyce F. Liu
This map shows the geographic impact of Joyce F. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce F. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce F. Liu more than expected).
Fields of papers citing papers by Joyce F. Liu
This network shows the impact of papers produced by Joyce F. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce F. Liu. The network helps show where Joyce F. Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joyce F. Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | Update on PARP inhibitors for the treatment of ovarian cancer. | 2025 | 2 |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 33 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 191 | |
| 14 | 2019 | 103 | |
| 15 | 2019 | 48 | |
| 16 | 2019 | 36 | |
| 17 | 2015 | 150 | |
| 18 | 2013 | 132 | |
| 19 | 2012 | 134 | |
| 20 | Molecular fingerprints and mechanisms of chemoresistance in ovarian cancer | 2008 | 1 |
About Joyce F. Liu
Joyce F. Liu is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology, having authored 184 papers that have together received 6.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (95 papers), PARP inhibition in cancer therapy (53 papers), Endometrial and Cervical Cancer Treatments (20 papers), BRCA gene mutations in cancer (18 papers), Cancer Genomics and Diagnostics (16 papers), Cancer Mechanisms and Therapy (15 papers), DNA Repair Mechanisms (13 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Reproductive Medicine (2.1k citations), Oncology (3.9k citations) and Cancer Research (903 citations). Joyce F. Liu has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Ursula A. Matulonis, Panagiotis A. Konstantinopoulos, Ronny Drapkin, Elise C. Kohn, Michelle S. Hirsch, Alan D. D’Andrea, Brooke E. Howitt, Dipanjan Chowdhury, Michael J. Birrer and Christin Whalen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.